Stay updated on Tezepelumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Tezepelumab in Chronic Urticaria Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a site maintenance/versioning update with no changes to the study data or page content.SummaryDifference0.0%

- Check28 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.4.2 has been added and the notices for v3.4.1 and the lapse in government funding have been removed; these are minor site maintenance updates and do not alter study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center operations with links to cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check71 days agoChange DetectedThe page adds a glossary toggle (Show glossary / Hide glossary) and includes minor textual updates for QC criteria labeling and FEAR Act Data capitalization. It also shows the new footer revision note 'Revision: v3.4.0' (replacing v3.3.4).SummaryDifference0.2%

- Check85 days agoChange DetectedUpdated the site revision from v3.3.3 to v3.3.4. No user-facing content or core functionality appears to be affected.SummaryDifference0.0%

Stay in the know with updates to Tezepelumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.